findmyKOL

Pam Taub, MD

Enriched profile

Professor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine; Founding Director, Step Family Foundation Cardiovascular Rehabilitation and Wellness Center · University of California San Diego Health System

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 La Jolla, CA · West · United StatesSpecialtyCardiovascular DiseaseFocusLipoproteins and Cardiovascular Health+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2018–2026

Pam Taub is Professor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine; Founding Director, Step Family Foundation Cardiovascular Rehabilitation and Wellness Center at University of California San Diego Health System. OpenAlex indexes 236 publications with 8,638 citations (h-index 41); ClinicalTrials.gov lists 16 registered studies with this person as an investigator.

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Pam Taub, MD, is Professor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine at University of California San Diego Health System (UC San Diego School of Medicine, Division of Cardiovascular Medicine). The public record shows 236 publications with 8,638 citations (h-index 41), centered on Lipoproteins and Cardiovascular Health, Heart Failure Treatment and Management, Dietary Effects on Health. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 43 companies, 1 NIH-funded awards (2018–2026).

  • Most recent indexed publication: 2026 · European heart journal
  • Top research focus: Lipoproteins and Cardiovascular Health
  • 16 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 43 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Metabolic Syndrome4 trialsType 2 Diabetes3 trialsCOVID-193 trialsTachycardia2 trialsPostural Orthostatic Tachycardia Syndrome2 trialsHeart Failure1 trialCoronary Artery Disease / ACS1 trialCoronary Artery Disease1 trialChronobiology Disorders1 trialObesity1 trialOverweight1 trialWeight Loss1 trialAlbuminuria1 trialDyslipidemia / Lipid Disorders

Research focus

OpenAlex concept fingerprint
Lipoproteins and Cardiovascular HealthHeart Failure Treatment and ManagementDietary Effects on HealthCardiac Health and Mental HealthDiet and metabolism studies

Drugs & molecules

across trials, industry payments and publications
Leqviogeneric · InclisiranClinical trials—Industry payments48Publications1Kerendiageneric · FinerenoneClinical trials—Industry payments41Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments31Publications—Nexletolgeneric · Bempedoic acidClinical trials—Industry payments26Publications—Nexlizetgeneric · Bempedoic acid / ezetimibeClinical trials—Industry payments20Publications—Saxendageneric · LiraglutideClinical trials—Industry payments19Publications—Xywavgeneric · OxybateClinical trials—Industry payments19Publications—Ozempicgeneric · SemaglutideClinical trials—Industry payments17Publications—Korlymgeneric · MifepristoneClinical trials—Industry payments14Publications—Repathageneric · EvolocumabClinical trials—Industry payments14Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments11Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments10Publications—

Works with

trial sponsors and companies reporting payments
Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments72Medtronic, Inc.Clinical trials—Industry payments72Merck Sharp & Dohme LLCClinical trials—Industry payments56Novartis Pharmaceuticals CorporationClinical trials—Industry payments51Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments43Novo Nordisk IncClinical trials—Industry payments43Eli Lilly and CompanyClinical trials—Industry payments34Amgen Inc.Clinical trials—Industry payments33Novo Nordisk ASClinical trials—Industry payments33Esperion Therapeutics, Inc.Clinical trials—Industry payments26Boehringer Ingelheim International GmbHClinical trials—Industry payments23Jazz Pharmaceuticals Inc.Clinical trials—Industry payments19Atricure, Inc.Clinical trials—Industry payments18Lilly USA, LLCClinical trials—Industry payments16Corcept TherapeuticsClinical trials—Industry payments14University of California, San DiegoClinical trials12Industry payments—Argenx Us, Inc.Clinical trials—Industry payments11AstraZeneca Pharmaceuticals LPClinical trials—Industry payments11Sanofi-Aventis U.S. LLCClinical trials—Industry payments10Edwards Lifesciences CorporationClinical trials—Industry payments6Novartis Pharma AGClinical trials—Industry payments6Roche Diagnostics International LtdClinical trials—Industry payments5Cleerly, Inc.Clinical trials—Industry payments4Heartflow, Inc.Clinical trials—Industry payments4Ionis Pharmaceuticals, Inc.Clinical trials—Industry payments4Kanecia Obie ZimmermanClinical trials3Industry payments—Amarin Pharma Inc.Clinical trials—Industry payments2CSL BehringClinical trials—Industry payments2Dexcom, Inc.Clinical trials—Industry payments2Impulse Dynamics (USA) Inc.Clinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
236publications

Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.

8,638citations

Total citations across indexed works.

41h-index

Hirsch index (OpenAlex). i10-index 104.

Clinical & industry

trials, payments and federal funding
16clinical trials

Investigator role on registered studies.

View trials ↓
43companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2018–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    76.5%
    Statin19.7%
    Rosuvastatin Calcium59%Atorvastatin Calcium32%Pravastatin Sodium9%
    Part D≥97 patients
    Beta blocker11.3%
    Metoprolol Succinate41%Carvedilol37%Bisoprolol Fumarate6%Propranolol Hcl6%Metoprolol Tartrate6%Propranolol Hcl Er4%
    Part D<11 patients

    + 20 more classes in this area

  • Metabolism & gastrointestinal

    11.8%
    SGLT2 inhibitor4.1%
    Jardiance100%
    Part D≥30 patients
    GLP-1 receptor agonist3.4%
    Ozempic88%Mounjaro12%
    Part D<11 patients

    + 4 more classes in this area

  • Blood & clotting

    10.3%
    Factor Xa inhibitor9.3%
    Eliquis77%Xarelto23%
    Part D≥49 patients
    P2Y12 inhibitor1.1%
    Clopidogrel100%
    Part D≥11 patients
All 6 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)87% facility · 13% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

1 NIH research award on record, funded 2018–2026 per NIH RePORTER. The latest:

Congress activity

Updated 14 Oct 2026

3 congress contributions (2016–2021) across AACE, ADA, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Alan S. Maisel34Michael J. Wilkinson25Iwona Świątkiewicz20Francisco Villarreal18Paul Clopton16Guillermo Ceballos16Emily N. C. Manoogian15Satchidananda Panda15Gary M. Vilke14Israel Ramírez‐Sánchez14Harpreet Bhatia12Kenneth McDonald11Nicholas Wettersten11Niall Mahon11Adena Zadourian11Julio Núñez11Claudio Passino11Chad Cannon11Carlo Briguori11Dirk J. van Veldhuisen11Patrick Murray11Michael C. Kontos11Christian Mueller11Gerasimos Filippatos10Robert R. Henry10Robert Birkhahn10Navaid Iqbal10Christie M. Ballantyne9Leonardo Salese8Michael D. Shapiro8Theodore P. Ciaraldi8Christopher J. Hogan8Hannah Lo8Richard M. Nowak8Arrash Fard8Neeja Patel7Ehtisham Mahmud7Deepak L. Bhatt7Gerhard Mueller7Mattheus Ramsis7

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/cv/pam-taub-md-slash-1

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/PamTaubMD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UCSDHealth/videos/focus-on-health-cardiovascular-care-with-cardiologist-pam-taub-md/2209562845877666

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • X / Twitter

    Active on X (Twitter) as @PamTaubMD, posting cardiology research and commentary

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Writing committee member

    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ahajournals.org ↗
  • Board member

    American Society of Preventive Cardiology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗
  • Member

    American Heart Association Women in Cardiology Committee (Council on Clinical Cardiology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsd.edu ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.